EPAX AS Patent applications |
Patent application number | Title | Published |
20130196393 | PROCESS FOR SEPARATING POLYUNSATURATED FATTY ACIDS FROM LONG CHAIN UNSATURATED OR LESS SATURATED FATTY ACIDS - A process for separating polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and eicosapen-taenoic acid (EPA) from less saturated long chain fatty acids (LCFAs) in a lipid composition, wherein said PUFAs and LCFAs are present as (i) triglycerides, or (ii) free fatty acids or monoalkyl esters, by exchange of at least a portion of LCFAs with short and/or medium chain fatty acids (MCFAs). The process can suitably be employed on marine derived oil, marine oil 2 derived oil products and other sources of PUFAs, including PUFA-rich singe cell oils (SCOs), and oils from genetically modified organisms with a modified lipid metabolism. The inventive process is based on novel use of lipases and distillation techniques, selectively chemically modifying species in the substrate material such that the desired species and chemically similar species become sufficiently dissimilar to be separable. Thus PUFA can be effectively enriched from material such as 30 herring oil with low PUFA content and high contant of equal length monounsaturated fatty acids such as 20:1 and 22:1 fatty acids. | 08-01-2013 |
20110212183 | ANTIOXIDANT COMPOSITION FOR MARINE OILS COMPRISING TOCOPHEROL, ROSEMARY EXTRACT, ASCORBIC ACID AND GREEN TEA EXTRACT - The present invention relates to compositions suitable for improving oxidative stability of marine oils, marine oils having improved oxidative stability as well as methods for manufacturing such compositions. | 09-01-2011 |
20100197785 | OMEGA-3 FATTY ACID FORTIFIED COMPOSITION - The present invention relates to an omega-3 fortified composition, method for its production and use of said composition as a nutritional, food or pharmaceutical composition. | 08-05-2010 |
20100081694 | COMPOSITION COMPRISING AT LEAST ONE PPAR AGONIST AND A LIPID COMPONENT - The present invention relates to compositions comprising at least one peroxisome proliferator-activated receptor (PPAR) agonist and a lipid component and to pharmaceutical ingredients comprising said ingredients. Such compositions are particularly suitable for the prophylaxis and/or the treatment of diseases such as diabetes, obesity and hypertriglyceridemia. | 04-01-2010 |